Literature DB >> 18762515

Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health.

Pascal M Lavoie1, Chandra Pham, Kerry L Jang.   

Abstract

OBJECTIVE: The goal was to determine the magnitude of genetic effects on susceptibility and risk factors for bronchopulmonary dysplasia by using the clinically validated National Institutes of Health consensus definition as a demonstrated proxy for long-term respiratory and neurodevelopmental outcomes in extremely low birth weight infants.
METHODS: We analyzed clinical data from twin pairs born at </=30 completed weeks of gestation in British Columbia, Canada, between 1993 and 2006. Differences in correlations between monozygotic and dizygotic twin pairs and model-fitting approaches were used to quantify the relative contributions of genetic, shared environmental, and nonshared environmental effects.
RESULTS: Among 318 twins of known zygosity, monozygotic twin pair similarities were greater than those observed for dizygotic pairs, which suggests significant heritability for bronchopulmonary dysplasia. Model-fitting analyses confirmed that genetic effects accounted for 82% and 79% of the observed variance in bronchopulmonary dysplasia susceptibility, defined on the basis of the need for supplemental oxygen at 36 weeks or the National Institutes of Health consensus definition, respectively. Variations in rates of hemodynamically significant patent ductus arteriosus were largely accounted for by genetic effects, whereas the observed variability in susceptibility to blood-borne bacterial infections was largely attributable to environmental factors, both common and unique to each infant.
CONCLUSIONS: Susceptibility to bronchopulmonary dysplasia and persistence of patent ductus arteriosus are both significantly heritable. Our study strengthens the case for investigating genetic risk stratification markers useful for predicting the most significant long-term respiratory and neurodevelopmental consequences of bronchopulmonary dysplasia in premature neonates.

Entities:  

Mesh:

Year:  2008        PMID: 18762515      PMCID: PMC4631604          DOI: 10.1542/peds.2007-2313

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  29 in total

Review 1.  Surfactant protein polymorphisms and neonatal lung disease.

Authors:  Mikko Hallman; Ritva Haataja
Journal:  Semin Perinatol       Date:  2006-12       Impact factor: 3.300

2.  Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia.

Authors:  Richard A Ehrenkranz; Michele C Walsh; Betty R Vohr; Alan H Jobe; Linda L Wright; Avroy A Fanaroff; Lisa A Wrage; Kenneth Poole
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

3.  Partial SP-B deficiency perturbs lung function and causes air space abnormalities.

Authors:  Lori L Nesslein; Kristin R Melton; Machiko Ikegami; Cheng-Lun Na; Susan E Wert; Ward R Rice; Jeffrey A Whitsett; Timothy E Weaver
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2005-02-18       Impact factor: 5.464

4.  Bronchopulmonary dysplasia: clinical presentation.

Authors:  E Bancalari; G E Abdenour; R Feller; J Gannon
Journal:  J Pediatr       Date:  1979-11       Impact factor: 4.406

Review 5.  The clever fetus: responding to inflammation to minimize lung injury.

Authors:  Boris W Kramer; Alan H Jobe
Journal:  Biol Neonate       Date:  2005

6.  Cutting edge: TLR4 deficiency confers susceptibility to lethal oxidant lung injury.

Authors:  Xuchen Zhang; Peiying Shan; Salman Qureshi; Robert Homer; Ruslan Medzhitov; Paul W Noble; Patty J Lee
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

7.  Developmental differences in the responses of IL-6 and IL-13 transgenic mice exposed to hyperoxia.

Authors:  Rayman Choo-Wing; Jonathan H Nedrelow; Robert J Homer; Jack A Elias; Vineet Bhandari
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-03-30       Impact factor: 5.464

8.  Deletion allele of angiotensin-converting enzyme is associated with increased risk and severity of bronchopulmonary dysplasia.

Authors:  S Nadya J Kazzi; Michael W Quasney
Journal:  J Pediatr       Date:  2005-12       Impact factor: 4.406

9.  Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1).

Authors:  Craig R Lee; Frank G Bottone; Joseph M Krahn; Leping Li; Harvey W Mohrenweiser; Molly E Cook; Robert M Petrovich; Douglas A Bell; Thomas E Eling; Darryl C Zeldin
Journal:  Pharmacogenet Genomics       Date:  2007-02       Impact factor: 2.089

10.  Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus closure in very low birth weight neonates.

Authors:  Andras Treszl; Miklos Szabo; Gyorgy Dunai; Andras Nobilis; Istvan Kocsis; Tamas Machay; Tivadar Tulassay; Barna Vasarhelyi
Journal:  Pediatr Res       Date:  2003-08-06       Impact factor: 3.756

View more
  77 in total

1.  Identification of SPOCK2 as a susceptibility gene for bronchopulmonary dysplasia.

Authors:  Alice Hadchouel; Xavier Durrmeyer; Emmanuelle Bouzigon; Roberto Incitti; Johanna Huusko; Pierre-Henri Jarreau; Richard Lenclen; Florence Demenais; Marie-Laure Franco-Montoya; Inès Layouni; Juliana Patkai; Jacques Bourbon; Mikko Hallman; Claude Danan; Christophe Delacourt
Journal:  Am J Respir Crit Care Med       Date:  2011-08-11       Impact factor: 21.405

Review 2.  Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Lewis H Romer; Bridget D Stuart; John D Coulson; Allen D Everett; Edward E Lawson; Joel I Brenner; Anna T Brown; Melanie K Nies; Priya Sekar; Lawrence M Nogee; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2012-07-06

3.  IL-18R1 and IL-18RAP SNPs may be associated with bronchopulmonary dysplasia in African-American infants.

Authors:  Joanna Floros; Douglas Londono; Derek Gordon; Patricia Silveyra; Susan L Diangelo; Rose M Viscardi; George S Worthen; Jeffrey Shenberger; Guirong Wang; Zhenwu Lin; Neal J Thomas
Journal:  Pediatr Res       Date:  2012-01       Impact factor: 3.756

4.  A genome-wide association study (GWAS) for bronchopulmonary dysplasia.

Authors:  Hui Wang; Krystal R St Julien; David K Stevenson; Thomas J Hoffmann; John S Witte; Laura C Lazzeroni; Mark A Krasnow; Cecele C Quaintance; John W Oehlert; Laura L Jelliffe-Pawlowski; Jeffrey B Gould; Gary M Shaw; Hugh M O'Brodovich
Journal:  Pediatrics       Date:  2013-07-29       Impact factor: 7.124

Review 5.  Genetics of bronchopulmonary dysplasia in the age of genomics.

Authors:  Pascal M Lavoie; Marie-Pierre Dubé
Journal:  Curr Opin Pediatr       Date:  2010-04       Impact factor: 2.856

6.  Surfactant protein B gene polymorphisms is associated with risk of bronchopulmonary dysplasia in Chinese Han population.

Authors:  Sheng Zhang; Xiaoying Zhang; Qiuping Li; Xiangyong Kong; Yupei Zhang; Xiujuan Wei; Jie Song; Zhichun Feng
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 7.  Impaired pulmonary vascular development in bronchopulmonary dysplasia.

Authors:  Christopher D Baker; Steven H Abman
Journal:  Neonatology       Date:  2015-06-05       Impact factor: 4.035

8.  Secreted phosphoprotein 1 is a determinant of lung function development in mice.

Authors:  Koustav Ganguly; Timothy M Martin; Vincent J Concel; Swapna Upadhyay; Kiflai Bein; Kelly A Brant; Leema George; Ankita Mitra; Tania A Thimraj; James P Fabisiak; Louis J Vuga; Cheryl Fattman; Naftali Kaminski; Holger Schulz; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

Review 9.  Progress in understanding the genetics of bronchopulmonary dysplasia.

Authors:  Gary M Shaw; Hugh M O'Brodovich
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

Review 10.  Accounting for multiple births in neonatal and perinatal trials: systematic review and case study.

Authors:  Anna Maria Hibbs; Dennis Black; Lisa Palermo; Avital Cnaan; Xianqun Luan; William E Truog; Michele C Walsh; Roberta A Ballard
Journal:  J Pediatr       Date:  2009-12-06       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.